Skip to content
TrialScanner

NCT04309084

Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma

Phase 1Unknown statusCELULead

Registry record

Lead sponsor
Celularity Incorporated
Conditions
Multiple Myeloma; Neoplasm, Plasma Cell; Neoplasms by Histologic Type; Neoplasms; Hemostatic Disorder
Primary completion
Jan 31, 2023Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04309084 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04309084: Natural Killer Cell (CYNK-001... | TrialScanner